285 related articles for article (PubMed ID: 19945534)
21. Pro-apoptotic Par-4 and dopamine D2 receptor in temporal cortex in schizophrenia, bipolar disorder and major depression.
Glantz LA; Gilmore JH; Overstreet DH; Salimi K; Lieberman JA; Jarskog LF
Schizophr Res; 2010 May; 118(1-3):292-9. PubMed ID: 20067857
[TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of brain enzymatic markers of arachidonic and docosahexaenoic acid metabolism in a rat model of the metabolic syndrome.
Taha AY; Gao F; Ramadan E; Cheon Y; Rapoport SI; Kim HW
BMC Neurosci; 2012 Oct; 13():131. PubMed ID: 23110484
[TBL] [Abstract][Full Text] [Related]
23. Regulation of the extrinsic and intrinsic apoptotic pathways in the prefrontal cortex of short- and long-term human opiate abusers.
García-Fuster MJ; Ramos-Miguel A; Rivero G; La Harpe R; Meana JJ; García-Sevilla JA
Neuroscience; 2008 Nov; 157(1):105-19. PubMed ID: 18834930
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor SP4 is reduced in postmortem cerebellum of bipolar disorder subjects: control by depolarization and lithium.
Pinacho R; Villalmanzo N; Lalonde J; Haro JM; Meana JJ; Gill G; Ramos B
Bipolar Disord; 2011; 13(5-6):474-85. PubMed ID: 22017217
[TBL] [Abstract][Full Text] [Related]
25. Regulators of mitochondrial complex I activity: A review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder.
Duong A; Che Y; Ceylan D; Pinguelo A; Andreazza AC; Trevor Young L; Berk M
Psychiatry Res; 2016 Feb; 236():148-157. PubMed ID: 26723136
[TBL] [Abstract][Full Text] [Related]
26. Bipolar disorder and mechanisms of action of mood stabilizers.
Rapoport SI; Basselin M; Kim HW; Rao JS
Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
[TBL] [Abstract][Full Text] [Related]
27. Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder.
Scarr E; Gray L; Keriakous D; Robinson PJ; Dean B
Bipolar Disord; 2006 Apr; 8(2):133-43. PubMed ID: 16542183
[TBL] [Abstract][Full Text] [Related]
28. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.
Vawter MP; Tomita H; Meng F; Bolstad B; Li J; Evans S; Choudary P; Atz M; Shao L; Neal C; Walsh DM; Burmeister M; Speed T; Myers R; Jones EG; Watson SJ; Akil H; Bunney WE
Mol Psychiatry; 2006 Jul; 11(7):615, 663-79. PubMed ID: 16636682
[TBL] [Abstract][Full Text] [Related]
29. Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.
Sinclair LI; Love S
J Alzheimers Dis; 2017; 59(3):1123-1137. PubMed ID: 28731446
[TBL] [Abstract][Full Text] [Related]
30. cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD).
Chang A; Li PP; Warsh JJ
Brain Res Mol Brain Res; 2003 Aug; 116(1-2):27-37. PubMed ID: 12941458
[TBL] [Abstract][Full Text] [Related]
31. P11 expression and PET in bipolar disorders.
Zhang L; Li CT; Su TP; Hu XZ; Lanius RA; Webster MJ; Chung MY; Chen YS; Bai YM; Barker JL; Barrett JE; Li XX; Li H; Benedek DM; Ursano R
J Psychiatr Res; 2011 Nov; 45(11):1426-31. PubMed ID: 21722919
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of synaptic protein mRNAs in STOP (MAP6) mutant mice.
Eastwood SL; Lyon L; George L; Andrieux A; Job D; Harrison PJ
J Psychopharmacol; 2007 Aug; 21(6):635-44. PubMed ID: 17050659
[TBL] [Abstract][Full Text] [Related]
33. Gene expression alterations in bipolar disorder postmortem brains.
Chen H; Wang N; Zhao X; Ross CA; O'Shea KS; McInnis MG
Bipolar Disord; 2013 Mar; 15(2):177-87. PubMed ID: 23360497
[TBL] [Abstract][Full Text] [Related]
34. Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.
Gilabert-Juan J; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Nácher J
Neurosci Lett; 2012 Nov; 530(1):97-102. PubMed ID: 23022470
[TBL] [Abstract][Full Text] [Related]
35. Mood-stabilizers target the brain arachidonic acid cascade.
Rao JS; Rapoport SI
Curr Mol Pharmacol; 2009 Jun; 2(2):207-14. PubMed ID: 20021459
[TBL] [Abstract][Full Text] [Related]
36. Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex.
Bezchlibnyk YB; Wang JF; McQueen GM; Young LT
J Neurochem; 2001 Nov; 79(4):826-34. PubMed ID: 11723175
[TBL] [Abstract][Full Text] [Related]
37. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.
Pandey GN; Rizavi HS; Tripathi M; Ren X
Bipolar Disord; 2015 Mar; 17(2):160-71. PubMed ID: 25041379
[TBL] [Abstract][Full Text] [Related]
38. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
39. Abnormal synaptic protein expression and cell death in murine scrapie.
Sisó S; Puig B; Varea R; Vidal E; Acín C; Prinz M; Montrasio F; Badiola J; Aguzzi A; Pumarola M; Ferrer I
Acta Neuropathol; 2002 Jun; 103(6):615-26. PubMed ID: 12012094
[TBL] [Abstract][Full Text] [Related]
40. Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood.
Glantz LA; Gilmore JH; Hamer RM; Lieberman JA; Jarskog LF
Neuroscience; 2007 Nov; 149(3):582-91. PubMed ID: 17916412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
